Checkpoints of B cell differentiation: Visualizing Ig-centric processes

Annals of the New York Academy of Sciences

Volumn 1246, Issue 1, 2011, Pages 11-25

  Berkowska, Magdalena A ^a   van der Burg, Mirjam ^a   van Dongen, Jacques J M ^a   van Zelm, Menno C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

B cell; Checkpoint; Differentiation; Immunoglobulin; Repertoire; Selection

Indexed keywords

IMMUNOGLOBULIN;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW; CELL MATURATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; LYMPHOID ORGAN; MEMORY CELL; NONHUMAN; PRE B LYMPHOCYTE;

EID: 84855303419     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06278.x     Document Type: Article

References (138)

1. Meffre, E. 2011. The establishment of early B cell tolerance in humans: Lessons from primary immunodeficiency diseases. Ann. N.Y. Acad. Sci. 1246: 1-10. doi:.
2. Tangye, S. 2011. T cell/B cell interactions in primary immunodeficiencies. Ann. N.Y. Acad. Sci. doi:.
3. Cerutti, A., M. Cols, M. Gentile, et al. 2011. Regulation of mucosal IgA responses: lessons from primary immunodeficiencies. Ann. N.Y. Acad. Sci. doi:.
4. Hozumi, N. & S. Tonegawa. 1976. Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions. Proc. Natl. Acad. Sci. USA 73: 3628-3632.
5. Tonegawa, S. 1983. Somatic generation of antibody diversity. Nature 302: 575-581.
6. Nutt, S.L. & B.L. Kee. 2007. The transcriptional regulation of B cell lineage commitment. Immunity 26: 715-725.
7. Zandi, S., D. Bryder & M. Sigvardsson. 2010. Load and lock: the molecular mechanisms of B-lymphocyte commitment. Immunol. Rev. 238: 47-62.
8. Kondo, M., I.L. Weissman & K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91: 661-672.
9. Akashi, K. et al. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404: 193-197.
10. DeKoter, R.P. & H. Singh. 2000. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288: 1439-1441.
11. Nichogiannopoulou, A. et al. 1999. Defects in hemopoietic stem cell activity in Ikaros mutant mice. J. Exp. Med. 190: 1201-1214.
12. Mansson, R. et al. 2008. B-lineage commitment prior to surface expression of B220 and CD19 on hematopoietic progenitor cells. Blood 112: 1048-1055.
13. Rumfelt, L.L. et al. 2006. Lineage specification and plasticity in CD19-early B cell precursors. J. Exp. Med. 203: 675-687.
14. Notta, F. et al. 2011. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 333: 218-221.
15. Galy, A. et al. 1995. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3: 459-473.
16. Sanz, E. et al. 2010. Ordering human CD34+CD10-CD19+ pre/pro-B-cell and CD19- common lymphoid progenitor stages in two pro-B-cell development pathways. Proc. Natl. Acad. Sci. USA 107: 5925-5930.
17. Ichii, M. et al. 2010. The density of CD10 corresponds to commitment and progression in the human B lymphoid lineage. PLoS One 5: e12954.
18. van Zelm, M.C. et al. 2005. Ig gene rearrangement steps are initiated in early human precursor B cell subsets and correlate with specific transcription factor expression. J. Immunol. 175: 5912-5922.
19. Bertrand, F.E., 3rd, et al. 1997. Ig D(H) gene segment transcription and rearrangement before surface expression of the pan-B-cell marker CD19 in normal human bone marrow. Blood 90: 736-744.
20. Meffre, E. et al. 1996. A human non-XLA immunodeficiency disease characterized by blockage of B cell development at an early proB cell stage. J. Clin. Invest. 98: 1519-1526.
21. van Gent, D.C. et al. 1997. Stimulation of V(D)J cleavage by high mobility group proteins. EMBO J. 16: 2665-2670.
22. McBlane, J.F. et al. 1995. Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 83: 387-395.
23. Hiom, K. & M. Gellert. 1997. A stable RAG1-RAG2-DNA complex that is active in V(D)J cleavage. Cell 88: 65-72.
24. Helmink, B.A. et al. 2009. MRN complex function in the repair of chromosomal Rag-mediated DNA double-strand breaks. J. Exp. Med. 206: 669-679.
25. van der Burg, M. et al. 2010. Loss of juxtaposition of RAG-induced immunoglobulin DNA ends is implicated in the precursor B-cell differentiation defect in NBS patients. Blood 115: 4770-4777.
26. Grawunder, U. & E. Harfst. 2001. How to make ends meet in V(D)J recombination. Curr. Opin. Immunol. 13: 186-194.
27. van Gent, D.C. & M. van der Burg. 2007. Non-homologous end-joining, a sticky affair. Oncogene 26: 7731-7740.
28. Gottlieb, T.M. & S.P. Jackson. 1993. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell 72: 131-142.
29. Nussenzweig, A. et al. 1996. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 382: 551-555.
30. Moshous, D. et al. 2001. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105: 177-186.
31. Schlissel, M.S. 1998. Structure of nonhairpin coding-end DNA breaks in cells undergoing V(D)J recombination. Mol. Cell. Biol. 18: 2029-2037.
32. Benedict, C.L. et al. 2000. Terminal deoxynucleotidyl transferase and repertoire development. Immunol. Rev. 175: 150-157.
33. Benedict, C.L., S. Gilfillan & J.F. Kearney. 2001. The long isoform of terminal deoxynucleotidyl transferase enters the nucleus and, rather than catalyzing nontemplated nucleotide addition, modulates the catalytic activity of the short isoform. J. Exp. Med. 193: 89-99.
34. Critchlow, S.E., R.P. Bowater & S.P. Jackson. 1997. Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV. Curr. Biol. 7: 588-598.
35. Grawunder, U. et al. 1997. Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature 388: 492-495.
36. Ahnesorg, P., P. Smith & S.P. Jackson. 2006. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 124: 301-313.
37. van der Burg, M. et al. 2009. A DNA-PKcs mutation in a radiosensitive T-B-SCID patient inhibits Artemis activation and nonhomologous end-joining. J. Clin. Invest. 119: 91-98.
38. van der Burg, M. et al. 2007. Defective Artemis nuclease is characterized by coding joints with microhomology in long palindromic-nucleotide stretches. Eur. J. Immunol. 37: 3522-3528.
39. van der Burg, M. et al. 2006. A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation. J. Clin. Invest. 116: 137-145.
40. Harfst, E. et al. 2000. Normal V(D)J recombination in cells from patients with Nijmegen breakage syndrome. Mol. Immunol. 37: 915-929.
41. Tsukada, S. et al. 1993. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72: 279-290.
42. Vetrie, D. et al. 1993. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361: 226-233.
43. Conley, M.E. et al. 2009. Primary B cell immunodeficiencies: comparisons and contrasts. Annu. Rev. Immunol. 27: 199-227.
44. Gauthier, L. et al. 2002. Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc. Natl. Acad. Sci. USA 99: 13014-13019.
45. Rossi, B. et al. 2006. Clustering of pre-B cell integrins induces galectin-1-dependent pre-B cell receptor relocalization and activation. J. Immunol. 177: 796-803.
46. Espeli, M. et al. 2009. Impaired B-cell development at the pre-BII-cell stage in galectin-1-deficient mice due to inefficient pre-BII/stromal cell interactions. Blood 113: 5878-5886.
47. van der Burg, M. et al. 2011. Dissection of B-cell development to unravel defects in patients with a primary antibody deficiency. Adv. Exp. Med. Biol. 697: 183-196.
48. Mostoslavsky, R. et al. 1998. Kappa chain monoallelic demethylation and the establishment of allelic exclusion. Genes Dev. 12: 1801-1811.
49. Maes, J. et al. 2001. Chromatin remodeling at the Ig loci prior to V(D)J recombination. J. Immunol. 167: 866-874.
50. McBlane, F. & J. Boyes. 2000. Stimulation of V(D)J recombination by histone acetylation. Curr. Biol. 10: 483-486.
51. Chowdhury, D. & R. Sen. 2001. Stepwise activation of the immunoglobulin mu heavy chain gene locus. EMBO J. 20: 6394-6403.
52. Yancopoulos, G.D. & F.W. Alt. 1985. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. Cell 40: 271-281.
53. Abarrategui, I. & M.S. Krangel. 2006. Regulation of T cell receptor-alpha gene recombination by transcription. Nat. Immunol. 7: 1109-1115.
54. Jhunjhunwala, S. et al. 2008. The 3D structure of the immunoglobulin heavy-chain locus: implications for long-range genomic interactions. Cell 133: 265-279.
55. Jhunjhunwala, S. et al. 2009. Chromatin architecture and the generation of antigen receptor diversity. Cell 138: 435-448.
56. Featherstone, K. et al. 2010. The mouse immunoglobulin heavy chain V-D intergenic sequence contains insulators that may regulate ordered V(D)J recombination. J. Biol. Chem. 285: 9327-9338.
57. Kosak, S.T. et al. 2002. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 296: 158-162.
58. Roldan, E. et al. 2005. Locus 'decontraction' and centromeric recruitment contribute to allelic exclusion of the immunoglobulin heavy-chain gene. Nat. Immunol. 6: 31-41.
59. Sayegh, C. et al. 2005. Visualization of looping involving the immunoglobulin heavy-chain locus in developing B cells. Genes Dev. 19: 322-327.
60. Fuxa, M. et al. 2004. Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Genes Dev. 18: 411-422.
61. Liu, H. et al. 2007. Yin Yang 1 is a critical regulator of B-cell development. Genes Dev. 21: 1179-1189.
62. Ebert, A. et al. 2011. The distal V(H) gene cluster of the Igh locus contains distinct regulatory elements with Pax5 transcription factor-dependent activity in pro-B cells. Immunity 34: 175-187.
63. Bertolino, E. et al. 2005. Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5. Nat. Immunol. 6: 836-843.
64. Malin, S. et al. 2010. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat. Immunol. 11: 171-179.
65. Nodland, S.E. et al. 2011. IL-7R expression and IL-7 signaling confer a distinct phenotype on developing human B-lineage cells. Blood 118: 2116-2127.
66. Engel, H., A. Rolink & S. Weiss. 1999. B cells are programmed to activate kappa and lambda for rearrangement at consecutive developmental stages. Eur. J. Immunol. 29: 2167-2176.
67. van der Burg, M. et al. 2001. Ordered recombination of immunoglobulin light chain genes occurs at the IGK locus but seems less strict at the IGL locus. Blood 97: 1001-1008.
68. Dingjan, G.M. et al. 2001. Bruton's tyrosine kinase regulates the activation of gene rearrangements at the lambda light chain locus in precursor B cells in the mouse. J. Exp. Med. 193: 1169-1178.
69. Beck, K. et al. 2009. Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci. J. Exp. Med. 206: 2271-2284.
70. Degner, S.C. et al. CCCTC-binding factor (CTCF) and cohesin influence the genomic architecture of the Igh locus and antisense transcription in pro-B cells. Proc. Natl. Acad. Sci. USA 108: 9566-9571.
71. Johnson, S.E. et al. 2005. Murine and human IL-7 activate STAT5 and induce proliferation of normal human pro-B cells. J. Immunol. 175: 7325-7331.
72. Lam, K.P., R. Kuhn & K. Rajewsky. 1997. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90: 1073-1083.
73. Torres, R.M. et al. 1996. Aberrant B cell development and immune response in mice with a compromised BCR complex. Science 272: 1804-1808.
74. Srinivasan, L. et al. 2009. PI3 kinase signals BCR-dependent mature B cell survival. Cell 139: 573-586.
75. Engelman, J.A., J. Luo & L.C. Cantley. 2006. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7: 606-619.
76. Cuss, A.K. et al. 2006. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J. Immunol. 176: 1506-1516.
77. Sims, G.P. et al. 2005. Identification and characterization of circulating human transitional B cells. Blood 105: 4390-4398.
78. van Zelm, M.C. et al. 2007. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J. Exp. Med. 204: 645-655.
79. Calandra, T. et al. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179: 1895-1902.
80. George, M. & J.H. Vaughan. 1962. In vitro cell migration as a model for delayed hypersensitivity. Proc. Soc. Exp. Biol. Med. 111: 514-521.
81. Gore, Y. et al. 2008. Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J. Biol. Chem. 283: 2784-2792.
82. Matza, D. et al. 2002. Invariant chain induces B cell maturation in a process that is independent of its chaperonic activity. Proc. Natl. Acad. Sci. USA 99: 3018-3023.
83. Shachar, I. & R.A. Flavell. 1996. Requirement for invariant chain in B cell maturation and function. Science 274: 106-108.
84. Sapoznikov, A. et al. 2008. Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches. Nat. Immunol. 9: 388-395.
85. Mackay, F. et al. 2003. BAFF and APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 21: 231-264.
86. Dillon, S.R. et al. 2006. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat. Rev. Drug Discov. 5: 235-246.
87. Gross, J.A. et al. 2000. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404: 995-999.
88. Marsters, S.A. et al. 2000. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr. Biol. 10: 785-788.
89. Thompson, J.S. et al. 2000. BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J. Exp. Med. 192: 129-135.
90. Wu, Y. et al. 2000. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J. Biol. Chem. 275: 35478-35485.
91. Yu, G. et al. 2000. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat. Immunol. 1: 252-256.
92. Thompson, J.S. et al. 2001. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293: 2108-2111.
93. Yan, M. et al. 2001. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr. Biol. 11: 1547-1552.
94. Hendriks, J. et al. 2005. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell. Death Differ. 12: 637-648.
95. Ingold, K. et al. 2005. Identification of proteoglycans as the APRIL-specific binding partners. J. Exp. Med. 201: 1375-1383.
96. Schneider, P. 2005. The role of APRIL and BAFF in lymphocyte activation. Curr. Opin. Immunol. 17: 282-289.
97. Gross, J.A. et al. 2001. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS. Immunity 15: 289-302.
98. Schiemann, B. et al. 2001. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293: 2111-2114.
99. Warnatz, K. et al. 2009. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc. Natl. Acad. Sci. USA 106: 13945-13950.
100. Carter, R.H. & D.T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256: 105-107.
101. van Noesel, C.J., A.C. Lankester & R.A. van Lier. 1993. Dual antigen recognition by B cells. Immunol. Today 14: 8-11.
102. Fearon, D.T. & M.C. Carroll. 2000. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18: 393-422.
103. Kimmig, L.M. et al. 2008. Further insights into human CD21 deficiency. Clin. Exp. Immunol. 154: 221-221 (abstract).
104. van Zelm, M.C. et al. 2006. An antibody-deficiency syndrome due to mutations in the CD19 gene. N. Engl. J. Med. 354: 1901-1912.
105. van Zelm, M.C. et al. 2010. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J. Clin. Invest. 120: 1265-1274.
106. Bretscher, P. & M. Cohn. 1970. A theory of self-nonself discrimination. Science 169: 1042-1049.
107. MacLennan, I.C. 1994. Germinal centers. Annu. Rev. Immunol. 12: 117-139.
108. Mond, J.J. et al. 1995. T cell independent antigens. Curr. Opin. Immunol. 7: 349-354.
109. Cerutti, A. 2008. The regulation of IgA class switching. Nat. Rev. Immunol. 8: 421-434.
110. Weill, J.C., S. Weller & C.A. Reynaud. 2009. Human marginal zone B cells. Annu. Rev. Immunol. 27: 267-285.
111. Delgado, M.F. et al. 2009. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat. Med. 15: 34-41.
112. Weller, S. et al. 2001. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc. Natl. Acad. Sci. USA 98: 1166-1170.
113. He, B. et al. 2010. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat. Immunol. 11: 836-845.
114. He, B. et al. 2007. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 26: 812-826.
115. Berkowska, M.A. et al. 2011. Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood 118: 2150-2158.
116. Fecteau, J.F., G. Cote & S. Neron. 2006. A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J. Immunol. 177: 3728-3736.
117. Wei, C. et al. 2007. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J. Immunol. 178: 6624-6633.
118. Weller, S. et al. 2004. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104: 3647-3654.
119. Agematsu, K. et al. 1998. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome. J. Clin. Invest. 102: 853-860.
120. Boursier, L. et al. 2005. Human intestinal IgA response is generated in the organized gut-associated lymphoid tissue but not in the lamina propria. Gastroenterology 128: 1879-1889.
121. Pugh-Bernard, A.E. et al. 2001. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J. Clin. Invest. 108: 1061-1070.
122. Wu, Y.C. et al. 2010. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood 116: 1070-1078.
123. Rajewsky, K. 1996. Clonal selection and learning in the antibody system. Nature 381: 751-758.
124. Potter, K.N. et al. 2002. Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen. J. Immunol. 169: 3777-3782.
125. Wardemann, H. et al. 2003. Predominant autoantibody production by early human B cell precursors. Science 301: 1374-1377.
126. Schmidlin, H., S.A. Diehl & B. Blom. 2009. New insights into the regulation of human B-cell differentiation. Trends Immunol. 30: 277-285.
127. Avery, D.T. et al. 2010. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J. Exp. Med. 207: 155-171.
128. Ettinger, R. et al. 2005. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175: 7867-7879.
129. Ozaki, K. et al. 2004. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 173: 5361-5371.
130. Diehl, S.A. et al. 2008. STAT3-mediated up-regulation of BLIMP1 is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J. Immunol. 180: 4805-4815.
131. Rozanski, C.H. et al. 2011. Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells. J. Exp. Med. 208: 1435-1446.
132. Bahlis, N.J. et al. 2007. CD28-mediated regulation of multiple myeloma cell proliferation and survival. Blood 109: 5002-5010.
133. Tu, Y., A. Gardner & A. Lichtenstein. 2000. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. Cancer Res. 60: 6763-6770.
134. Caraux, A. et al. 2010. Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells. Haematologica 95: 1016-1020.
135. Mei, H.E. et al. 2009. Blood-borne human plasma cells in steady state are derived from mucosal immune responses. Blood 113: 2461-2469.
136. Odendahl, M. et al. 2005. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 105: 1614-1621.
137. Perez-Andres, M. et al. 2010. Human peripheral blood B-cell compartments: a crossroad in B-cell traffic. Cytometry B Clin. Cytom. 78(Suppl 1): S47-S60.
138. Driessen, G.J. et al. 2011. B-cell replication history and somatic hypermutation status identify distinct pathophysiological backgrounds in common variable immunodeficiency. Blood [Epub ahead of print] PMID: 22042693. doi:.